Fetal gene editing would be less invasive than that, Peranteau said. It would be similar to how doctors routinely treat unborn babies diagnosed with fetal anemia by performing a blood transfusion through the umbilical vein.
Musunuru and Peranteau have seen promising early results in animals. But they are at least three years away from trying the approach in humans and careful to temper expectations, worrying that they might give families false hope. While the scientists believe they could treat heart and muscle disorders, getting past the blood-brain barrier still remains difficult. That means, for now, neurological conditions are off the table.
The scientists plan to make edits to what are called somatic cells. They want to steer clear of editing reproductive cells, an approach that has become one of science’s biggest controversies. To many researchers, editing those cells crosses an ethical line because it can affect future generations and lead to so-called “designer babies” whose parents could modify their genes to make their descendants taller or faster. After a scientist revealed in 2018 that he had edited embryos of twin girls to protect them from HIV, a Chinese court sentenced him to three years in prison. Despite the controversy, some researchers are studying DNA editing of embryos.
